118 related articles for article (PubMed ID: 15357904)
1. High-risk papillomavirus infection is associated with altered antibody responses in genital tract: non-specific responses in HPV infection.
Bard E; Riethmuller D; Meillet D; Prétet JL; Schaal JP; Mougin C; Seillès E
Viral Immunol; 2004; 17(3):381-9. PubMed ID: 15357904
[TBL] [Abstract][Full Text] [Related]
2. Validation of a high sensitive immunoenzymatic assay to establish the origin of immunoglobulins in female genital secretions.
Bard E; Riethmuller D; Biichlé S; Meillet D; Prétet JL; Mougin C; Seillès E
J Immunoassay Immunochem; 2002; 23(2):145-62. PubMed ID: 12033640
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Immunoglobulin A/G Responses During 3 Doses of the Human Papillomavirus-16/18 ASO4-Adjuvanted Vaccine.
Gonçalves AK; Giraldo PC; Farias KJ; Machado PR; Costa AP; de Souza LC; Crispim JC; Eleutério J; Witkin SS
Sex Transm Dis; 2016 May; 43(5):335-9. PubMed ID: 27100772
[TBL] [Abstract][Full Text] [Related]
4. Human T-lymphotropic virus type I excretion and specific antibody response in paired saliva and cervicovaginal secretions.
Belec L; Jean Georges A; Hallouin MC; Si Mohamed A; Morand-Joubert L; Georges-Courbot MC
AIDS Res Hum Retroviruses; 1996 Jan; 12(2):157-167. PubMed ID: 8834466
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection.
Bélec L; Tévi-Bénissan C; Dupré T; Mohamed AS; Prazuck T; Gilquin J; Kanga JM; Pillot J
J Clin Immunol; 1996 Jan; 16(1):12-20. PubMed ID: 8926281
[TBL] [Abstract][Full Text] [Related]
6. Serum and cervicovaginal IgG immune responses against α7 and α9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination.
Mboumba Bouassa RS; Péré H; Gubavu C; Prazuck T; Jenabian MA; Veyer D; Meye JF; Touzé A; Bélec L
PLoS One; 2020; 15(5):e0233084. PubMed ID: 32421735
[TBL] [Abstract][Full Text] [Related]
7. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.
Fiore JR; Laddago V; Lepera A; La Grasta L; Di Stefano M; Saracino A; Lopalco P; Pastore G; Angarano G
New Microbiol; 2000 Jan; 23(1):85-92. PubMed ID: 10946410
[TBL] [Abstract][Full Text] [Related]
8. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection.
Bélec L; Dupré T; Prazuck T; Tévi-Bénissan C; Kanga JM; Pathey O; Lu XS; Pillot J
J Infect Dis; 1995 Sep; 172(3):691-7. PubMed ID: 7658060
[TBL] [Abstract][Full Text] [Related]
9. Seric and local antibodies against a synthetic peptide of HPV16.
Dreyfus M; Baldauf JJ; Ritter J; Obert G
Eur J Obstet Gynecol Reprod Biol; 1995 Apr; 59(2):187-91. PubMed ID: 7657014
[TBL] [Abstract][Full Text] [Related]
10. Infection and vaccine-induced HPV-specific antibodies in cervicovaginal secretions. A review of the literature.
Pattyn J; Van Keer S; Tjalma W; Matheeussen V; Van Damme P; Vorsters A
Papillomavirus Res; 2019 Dec; 8():100185. PubMed ID: 31494291
[TBL] [Abstract][Full Text] [Related]
11. Activation of the Complement System in the Lower Genital Tract During Pregnancy and Delivery.
Livson S; Jarva H; Kalliala I; Lokki AI; Heikkinen-Eloranta J; Nieminen P; Meri S
Front Immunol; 2020; 11():563073. PubMed ID: 33505390
[TBL] [Abstract][Full Text] [Related]
12. Characterization of IgA response among women with incident HPV 16 infection.
Onda T; Carter JJ; Koutsky LA; Hughes JP; Lee SK; Kuypers J; Kiviat N; Galloway DA
Virology; 2003 Jul; 312(1):213-21. PubMed ID: 12890634
[TBL] [Abstract][Full Text] [Related]
13. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women.
Petter A; Heim K; Guger M; Ciresa-Kö Nig A; Christensen N; Sarcletti M; Wieland U; Pfister H; Zangerle R; Höpfl R
J Gen Virol; 2000 Mar; 81(Pt 3):701-8. PubMed ID: 10675407
[TBL] [Abstract][Full Text] [Related]
14. Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine.
Schwarz TF; Kocken M; Petäjä T; Einstein MH; Spaczynski M; Louwers JA; Pedersen C; Levin M; Zahaf T; Poncelet S; Hardt K; Descamps D; Dubin G
Hum Vaccin; 2010 Dec; 6(12):1054-61. PubMed ID: 21157180
[TBL] [Abstract][Full Text] [Related]
15. Cervicovaginal synthesis of IgG antibodies to the immunodominant 175-199 domain of the surface glycoprotein gp46 of human T-cell leukemia virus type I.
Bélec L; Georges-Courbot MC; Georges A; Mohamed AS; Londos-Gagliardi D; Hallouin MC; Hocini H; Guillemain B
J Med Virol; 1996 Sep; 50(1):42-9. PubMed ID: 8890040
[TBL] [Abstract][Full Text] [Related]
16. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Viscidi RP; Ahdieh-Grant L; Schneider MF; Clayman B; Massad LS; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine A; Strickler H
J Infect Dis; 2003 Dec; 188(12):1834-44. PubMed ID: 14673762
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of methods for collection and measurement of cytokines and immunoglobulins in cervical and vaginal secretions of HIV and HPV infected women.
Snowhite IV; Jones WE; Dumestre J; Dunlap K; Braly PS; Hagensee ME
J Immunol Methods; 2002 May; 263(1-2):85-95. PubMed ID: 12009206
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of HIV-1-specific IgG, IgA, and IgM antibodies in human genital tract secretions.
Haimovici F; Mayer KH; Anderson DJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul; 15(3):185-91. PubMed ID: 9257652
[TBL] [Abstract][Full Text] [Related]
19. [Determination of secretory immunoglobulin A in cervicovaginal secretions of healthy women with an ELISA method].
Mendling W; Metzger P
Geburtshilfe Frauenheilkd; 1994 Jul; 54(7):417-20. PubMed ID: 7926576
[TBL] [Abstract][Full Text] [Related]
20. Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles.
Nardelli-Haefliger D; Wirthner D; Schiller JT; Lowy DR; Hildesheim A; Ponci F; De Grandi P
J Natl Cancer Inst; 2003 Aug; 95(15):1128-37. PubMed ID: 12902442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
